Cold Therapy in the Treatment of Exercise-induced Muscle Damage

Sponsor
University of Brasilia (Other)
Overall Status
Completed
CT.gov ID
NCT02341612
Collaborator
Conselho Nacional de Desenvolvimento Científico e Tecnológico (Other)
65
1
5
8
8.1

Study Details

Study Description

Brief Summary

Subjects were randomly placed in five groups: (1) single exposure at 5°C in cold water immersion, (2) single exposure at 15°C in cold water immersion, (3) multiple exposures at 10°C in cold water immersion, (4) whole body cryotherapy (WBC) at 110°C and (5) passive recovery (control group). The single exposure groups performed cold water immersion immediately after exercise-induced muscle damage (EIMD) for 20 minutes. The multiple exposures group performed cold water immersion immediately, 24h, 48h and 72h after EIMD (once a day) for 20 minutes. The WBC group remained in the cabin immediately after EIMD for 3 min. The control group was not exposed to treatment after the EIMD protocol. The subjects were asked to visit the laboratory on seven occasions. The first visit was the familiarization of the subjects with experimental procedures and their anthropometric assessment. One week after familiarization, on visit two, volunteers performed the exercise-induced muscle damage (EIMD) protocol and they were allocated to one of experimental groups. Indirect markers of muscle damage and inflammatory responses were evaluated at baseline (pre), immediately post, 24h, 48h, 72h, 96h, and 168h following the EIMD protocol by measuring anterior thigh muscle swelling, isometric knee extensors peak torque, knee extensors muscle soreness, countermovement vertical jump and blood sample analyzes.

Condition or Disease Intervention/Treatment Phase
  • Other: single exposure at 5°C in CWI
  • Other: single exposure at 15°C in CWI
  • Other: multiple exposures at 10°C in CWI
  • Other: whole body cryotherapy (WBC)
  • Other: passive recovery
N/A

Detailed Description

To avoid circadian influences, subjects were asked to visit the laboratory always at the same time of day. Volunteers were asked to not perform any vigorous physical activities or unaccustomed exercise during the experiment period. In addition, they were instructed not to intake medications or supplements during the study.

Study Design

Study Type:
Interventional
Actual Enrollment :
65 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effects of Different Cold Therapy Modalities on Muscular Recovery and Inflammatory Responses Following Exercise-induced Muscle Damage in Healthy Men
Study Start Date :
Dec 1, 2013
Actual Primary Completion Date :
Aug 1, 2014
Actual Study Completion Date :
Aug 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: single exposure at 5°C in CWI

The subjects of this group performed cold water immersion (CWI) immediately after exercise-induced muscle damage (EIMD) a single exposure at 5°C for 20 minutes.

Other: single exposure at 5°C in CWI
The subjects of this group performed cold water immersion immediately after exercise-induced muscle damage (EIMD) a single exposure at 5°C for 20 minutes.

Experimental: single exposure at 15°C in CWI

The subjects of this group performed CWI immediately after EIMD a single exposure at 15°C for 20 minutes.

Other: single exposure at 15°C in CWI
The subjects of this group performed CWI immediately after EIMD a single exposure at 15°C for 20 minutes.

Experimental: multiple exposures at 10°C in CWI

The subjects of this group performed CWI immediately, 24h, 48h and 72h after EIMD (once a day) for 20 minutes.

Other: multiple exposures at 10°C in CWI
The subjects of this group performed CWI immediately, 24h, 48h and 72h after EIMD (once a day) for 20 minutes.

Experimental: whole body criotherapy (WBC)

The whole body criotherapy (WBC) group remained in the cabin immediately after EIMD for 3 minutes.

Other: whole body cryotherapy (WBC)
The whole body criotherapy (WBC) group remained in the cabin immediately after EIMD for 3 minutes.

Experimental: passive recovery

The control group was not exposed to treatment after the EIMD protocol.

Other: passive recovery
The control group was exposed to treatment after the EIMD protocol.

Outcome Measures

Primary Outcome Measures

  1. Change of knee extensors muscle maximal isometric voluntary contraction during 168h post exercise-induced muscle damage (EIMD), assessed using isokinetic dynamometer [at baseline (pre) and at 0, 24, 48, 72, 96, and 168 hours after exercise-induced muscle damage.]

Secondary Outcome Measures

  1. Change of the anterior thigh muscle swelling during 168h post EIMD, assessed using ultrasound device [at baseline (pre) and at 0, 24, 48, 72, 96, and 168 hours after exercise-induced muscle damage.]

  2. Change of the knee extensors muscle soreness during 168h post EIMD, assessed using a Visual Analogue Scale [at baseline (pre) and at 0, 24, 48, 72, 96, and 168 hours after exercise-induced muscle damage.]

  3. Change of inflammatory response (Tumor Necrosis Factor-α, interleukin-6, interleukin-10, interleukin-1β, interleukin-1ra) during 168h post EIMD, assessed by blood sample analyzes [at baseline (pre) and at 0, 24, 48, 72, 96, and 168 hours after exercise-induced muscle damage.]

  4. Change on the performance of countermovement vertical jump during 168h post EIMD, assessed using a force plate [at baseline (pre) and at 0, 24, 48, 72, 96, and 168 hours after exercise-induced muscle damage.]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • College students were eligible for inclusion.
Exclusion Criteria:
  • Exclusion criteria included a history of eccentric quadriceps exercise in the past 3 months

  • A history of quadriceps muscle tear

  • Neurological disease involving the lower limbs

  • Current lower-limb musculoskeletal injury and thigh skinfold thickness >20 mm..

  • Participants with potential vascular problems which cold therapy is contraindicated (eg, diagnoses of diabetes or Raynaud's disease) were also excluded

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Brasília Brasília DF Brazil 72220-900

Sponsors and Collaborators

  • University of Brasilia
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Angelina Freitas Siqueira, Angelina Freitas Siqueira, University of Brasilia
ClinicalTrials.gov Identifier:
NCT02341612
Other Study ID Numbers:
  • CEP/FS-UnB 234/13
First Posted:
Jan 19, 2015
Last Update Posted:
Jan 19, 2015
Last Verified:
Jan 1, 2015
Keywords provided by Angelina Freitas Siqueira, Angelina Freitas Siqueira, University of Brasilia

Study Results

No Results Posted as of Jan 19, 2015